The Cooper Companies, Inc. (NASDAQ:COO) Position Boosted by Headlands Technologies LLC

Key Points

• Headlands Technologies LLC has increased its holdings in The Cooper Companies by 64.2%, owning 83,361 shares after acquiring an additional 32,607 shares during the first quarter.
• Deutsche Bank AG and Goldman Sachs Group Inc. are among other institutional investors that have boosted their stakes in Cooper Companies, with Deutsche Bank increasing its holdings by 10.3% to over 1.28 million shares.
• Analysts have mixed views on Cooper Companies, with BNP Paribas upgrading the stock to a "strong-buy" rating, while Wells Fargo has adjusted its price target down from $118 to $93.

Headlands Technologies LLC increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 64.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 83,361 shares of the medical device company's stock after buying an additional 32,607 shares during the period. Cooper Companies comprises approximately 0.8% of Headlands Technologies LLC's holdings, making the stock its 22nd biggest holding. Headlands Technologies LLC's holdings in Cooper Companies were worth $7,032,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. City Holding Co. acquired a new position in shares of Cooper Companies in the first quarter worth about $34,000. Covestor Ltd increased its holdings in Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares during the last quarter. Larson Financial Group LLC raised its position in shares of Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after purchasing an additional 664 shares in the last quarter. HM Payson & Co. boosted its stake in shares of Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after buying an additional 532 shares during the last quarter. Finally, UMB Bank n.a. grew its position in shares of Cooper Companies by 16.7% during the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after buying an additional 129 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Performance

NASDAQ COO traded up $1.09 during trading hours on Friday, reaching $70.29. The company's stock had a trading volume of 954,675 shares, compared to its average volume of 2,040,357. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The business has a 50-day simple moving average of $71.53 and a 200 day simple moving average of $79.95. The stock has a market cap of $14.06 billion, a PE ratio of 34.12, a PEG ratio of 1.69 and a beta of 1.00. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.03. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The firm's revenue for the quarter was up 6.3% on a year-over-year basis. During the same period last year, the company earned $0.85 earnings per share. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on COO shares. Wells Fargo & Company cut their price target on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a report on Friday, May 30th. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Needham & Company LLC raised shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price target on the stock in a research report on Tuesday, June 17th. BNP Paribas raised Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Finally, UBS Group upgraded Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. Three equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $96.73.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.